Search Results 431-440 of 16662 for Androgens
Latest stories · New study links genetic variation to chemotherapy-related liver damage in patients with colorectal cancer · Stem cells may offer new hope for end ...
... Androgen blockers, Luteinizing hormone-releasing hormone (LHRH) agonists or antagonists (12 month wash-out), or. Testosterone supplementation 8. Active ...
Mayo Clinic uses gene editing to reverse inherited kidney disease in preclinical study featured image · Rewriting the future of rheumatoid arthritis: How early ...
Julie Ferris-Tillman, Ph.D. July 15, 2026. New technology could improve donor liver evaluation before transplantation featured image.
Learn about navigating regulatory pathways that advance promising biotherapies to daily patient care at RegenBio Summit: Transforming Next-Gen Biotherapeutics ...
To combat heart disease and cancer, genomics researcher looks abroad featured image · More Mayo neuroscience: Brain cells 'crosstalk' and cancer growth; ...
How researchers are using AI to accelerate the path to cures (VIDEO) featured image · Mayo Clinic study finds 1 in 8 adults carries hidden genetic risk — and ...
At Mayo Clinic, biomedical engineer Benjamin Brinkmann, Ph.D., is developing tools and technologies that help reveal brain patterns — making epileptic seizures ...
Has ongoing androgen deprivation with serum testosterone <50 ng/dL (<2.0 nM). Treatment with luteinizing hormone-releasing hormone agonists or antagonists ...
Prior treatment required: Anti-androgen/androgen-deprivation therapy (e.g., enzalutamide, leuprolide, degarelix) at any time prior registration. Provide ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.